By Jennifer Zeitzer

On June 4, the Veterans Administration (VA) Office of Research and Development announced that Timothy J. O’Leary, MD, PhD, was promoted to Chief Research and Development Officer (CRADO). He had been serving as acting CRADO since June 2013, following the retirement of Joel Kupersmith, MD. Dr. O’Leary is a member of two FASEB societies: the American Society for Investigative Pathology and the Association for Molecular Pathology. He also serves on FASEB’s Research Information Technology Subcommittee.

As CRADO, Dr. O’Leary will manage the Medical and Prosthetic Research Program, the primary federal effort addressing the health needs of America’s veterans. Dr. O’Leary received his PhD in physical chemistry from Stanford University and his MD from the University of Michigan. Board certified in anatomic pathology and molecular genetic pathology, he was the Chairman of the Department of Cellular Pathology at the Armed Forces Institute of Pathology before joining the VA in 2004. During his decade at the VA, Dr. O’Leary has served in several capacities including as Director of Biomedical Laboratory Research and Development and Director of Clinical Services Research and Development. He holds three patents, has authored or co-authored nearly 200 journal articles.

Timothy O’Leary, MD, PhD. Photo courtesy of the Veterans Administration